Monash Ivf Group Ltd
Monash IVF Group Limited engages in the provision of assisted reproductive and specialist women imaging services in Australia and Malaysia. It offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. It also provides tertiary level prenatal diagnostic, and IVF treatment services. Monash IVF Group Limited was incorporated in 2014 and is headquartered in Richmond, Au… Read more
Market Cap & Net Worth: Monash Ivf Group Ltd (MVF)
Monash Ivf Group Ltd (AU:MVF) has a market capitalization of $154.40 Million (AU$249.37 Million) as of March 18, 2026. Listed on the AU stock exchange, this Australia-based company holds position #17570 globally and #260 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Monash Ivf Group Ltd's stock price AU$0.64 by its total outstanding shares 389634840 (389.63 Million).
Monash Ivf Group Ltd Market Cap History: 2015 to 2026
Monash Ivf Group Ltd's market capitalization history from 2015 to 2026. Data shows change from $243.79 Million to $154.40 Million (-2.62% CAGR).
Index Memberships
Monash Ivf Group Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P/ASX 300
AXKO
|
$548.39 Billion | 0.02% | #123 of 300 |
|
ASX Small Ordinaries
AXSO
|
$70.56 Billion | 0.17% | #92 of 200 |
Weight: Monash Ivf Group Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Monash Ivf Group Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Monash Ivf Group Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.65x
Monash Ivf Group Ltd's market cap is 0.65 times its annual revenue
0.69x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
7.09x
Monash Ivf Group Ltd's market cap is 7.09 times its annual earnings
363.13x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $324.78 Million | $156.56 Million | $28.77 Million | 2.07x | 11.29x |
| 2017 | $210.26 Million | $155.18 Million | $29.62 Million | 1.35x | 7.10x |
| 2018 | $174.62 Million | $150.64 Million | $21.35 Million | 1.16x | 8.18x |
| 2019 | $192.26 Million | $151.98 Million | $19.85 Million | 1.27x | 9.68x |
| 2020 | $159.81 Million | $145.42 Million | $11.73 Million | 1.10x | 13.63x |
| 2021 | $225.65 Million | $183.60 Million | $25.15 Million | 1.23x | 8.97x |
| 2022 | $213.03 Million | $192.29 Million | $18.41 Million | 1.11x | 11.57x |
| 2023 | $301.79 Million | $213.59 Million | $21.84 Million | 1.41x | 13.82x |
| 2024 | $306.40 Million | $254.96 Million | -$6.53 Million | 1.20x | N/A |
| 2025 | $177.32 Million | $271.92 Million | $25.01 Million | 0.65x | 7.09x |
Competitor Companies of MVF by Market Capitalization
Companies near Monash Ivf Group Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to Monash Ivf Group Ltd by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #90 globally with a market cap of $177.20 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #151 globally with a market cap of $122.79 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.38 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #511 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #90 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.20 Billion | $472.71 |
| #151 | Danaher Corporation | NYSE:DHR | $122.79 Billion | $195.21 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.38 Billion | $586.98 |
| #511 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
Monash Ivf Group Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Monash Ivf Group Ltd's market cap moved from $243.79 Million to $ 154.40 Million, with a yearly change of -2.62%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$154.40 Million | -12.93% |
| 2025 | AU$177.32 Million | -42.13% |
| 2024 | AU$306.40 Million | +1.53% |
| 2023 | AU$301.79 Million | +41.66% |
| 2022 | AU$213.03 Million | -5.59% |
| 2021 | AU$225.65 Million | +41.20% |
| 2020 | AU$159.81 Million | -16.88% |
| 2019 | AU$192.26 Million | +10.10% |
| 2018 | AU$174.62 Million | -16.95% |
| 2017 | AU$210.26 Million | -35.26% |
| 2016 | AU$324.78 Million | +33.22% |
| 2015 | AU$243.79 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Monash Ivf Group Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $154.40 Million USD |
| MoneyControl | $154.40 Million USD |
| MarketWatch | $154.40 Million USD |
| marketcap.company | $154.40 Million USD |
| Reuters | $154.40 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.